June 4, 2020 / 6:45 AM / a month ago

BRIEF-AstraZeneca Collaborates With Accent Therapeutics

June 4 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA TO DISCOVER AND DEVELOP NOVEL THERAPIES TARGETING RNA-MODIFYING PROTEINS IN ONCOLOGY COLLABORATION WITH ACCENT THERAPEUTICS

* ASTRAZENECA - ACCENT WILL RECEIVE AN UPFRONT PAYMENT OF $55M

* ASTRAZENECA - ACCENT IS ALSO ELIGIBLE TO RECEIVE ADDITIONAL SUCCESS-BASED PAYMENTS ACROSS ALL PROGRAMMES IN FORM OF OPTION FEES AND MILESTONE PAYMENTS

* ASTRAZENECA - IN EVENT ACCENT OPTS INTO CO-DEVELOPING AND CO-COMMERCIALISING NOMINATED PROGRAMME, PROFITS AND LOSSES WILL BE SPLIT IN US Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below